Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10

被引:659
作者
Stumhofer, Jason S.
Silver, Jonathan S.
Laurence, Arian
Porrett, Paige M.
Harris, Tajie H.
Turka, Laurence A.
Ernst, Matthias
Saris, Christiaan J. M.
O'Shea, John J.
Hunter, Christopher A. [1 ]
机构
[1] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
[2] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Ludwig Inst Canc Res, Parkville, Vic 3050, Australia
[5] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1038/ni1537
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 10 (IL-10) has a prominent function in regulating the balance between protective and pathological T cell responses. Consistent with that activity, many sources of this cytokine are found in vivo, including from myeloid cells and a variety of T cell subsets. However, although there are many pathways that regulate innate production of IL-10, the factors that govern its synthesis by the adaptive response are poorly understood. Here we report that IL-27 and IL-6 induced T helper type 1 and type 2 cells, as well as T helper cells that produce IL-17, to secrete IL-10. This effect was dependent on the transcription factors STAT1 and STAT3 for IL-27 and on STAT3 for IL-6. Our studies identify a previously unknown pathway that allows the immune system to temper inflammatory responses.
引用
收藏
页码:1363 / U5
页数:10
相关论文
共 58 条
[1]   TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1 [J].
Amadi-Obi, Ahjoku ;
Yu, Cheng-Rong ;
Liu, Xuebin ;
Mahdi, Rashid M. ;
Clarke, Grace Levy ;
Nussenblatt, Robert B. ;
Gery, Igal ;
Lee, Yun Sang ;
Egwuagu, Charles E. .
NATURE MEDICINE, 2007, 13 (06) :711-718
[2]   CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis [J].
Anderson, Charles F. ;
Oukka, Mohammed ;
Kuchroo, Vijay J. ;
Sacks, David .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (02) :285-297
[3]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[4]   Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells [J].
Batten, Marcel ;
Li, Ji ;
Yi, Sothy ;
Kljavin, Noelyn M. ;
Danilenko, Dimitry M. ;
Lucas, Sophie ;
Lee, James ;
de Sauvage, Frederic J. ;
Ghilardi, Nico .
NATURE IMMUNOLOGY, 2006, 7 (09) :929-936
[5]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[6]   A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages [J].
Brightbill, HD ;
Plevy, SE ;
Modlin, RL ;
Smale, ST .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :1940-1951
[7]   Development of Th1-type immune responses requires the type I cytokine receptor TCCR [J].
Chen, Q ;
Ghilardi, N ;
Wang, H ;
Baker, T ;
Xie, MH ;
Gurney, A ;
Grewal, IS ;
de Sauvage, FJ .
NATURE, 2000, 407 (6806) :916-920
[8]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886
[9]   Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells [J].
Chen, Zhi ;
Laurence, Arian ;
Kanno, Yuka ;
Pacher-Zavisin, Margit ;
Zhu, Bing-Mei ;
Tato, Cristina ;
Yoshimura, Akihiko ;
Hennighausen, Lothar ;
O'Shea, John J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (21) :8137-8142
[10]   Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target [J].
Chiarle, R ;
Simmons, WJ ;
Cai, HY ;
Dhall, G ;
Zamo', A ;
Raz, R ;
Karras, JG ;
Levy, DE ;
Inghirami, G .
NATURE MEDICINE, 2005, 11 (06) :623-629